News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Conference News TCT 2022 Dedicated Catheter for Acute PE Shows Promise in IDE Trial L.A. McKeown September 17, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Conference News ESC 2020 Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism Caitlin E. Cox September 04, 2020
News Daily News COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients Caitlin E. Cox July 24, 2020
News Daily News Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers Yael L. Maxwell September 20, 2019
News Conference News TCT 2018 Novel LAA Closure Device Shows Promise in Early Experience L.A. McKeown September 22, 2018
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Daily News Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib Todd Neale June 27, 2016
News Daily News Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib L.A. McKeown August 09, 2012